Register entry
Vifor (International) AG
- Registered sites
- 1
- Drug products
- 13
- Live patents
- 40
- Countries
- 1
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Vifor (International) Inc. | St. GallenSwitzerland | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002808450 |
Exclusivity
Patents
40Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| KORSUVA | DIFELIKEFALIN ACETATE | Nov 2027 |
| KORSUVA | DIFELIKEFALIN ACETATE | Nov 2032 |
| VELTASSA | PATIROMER SORBITEX CALCIUM | Mar 2027 |
| VELTASSA | PATIROMER SORBITEX CALCIUM | May 2027 |
| VELTASSA | PATIROMER SORBITEX CALCIUM | Jun 2028 |
| VELTASSA | PATIROMER SORBITEX CALCIUM | May 2030 |
| VELTASSA | PATIROMER SORBITEX CALCIUM | Oct 2033 |
Catalogue
Marketed products
13Showing 13 of 13.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Ferric Carboxymaltose | POWDER | BULK INGREDIENT |
| - | Iron Sucrose | LIQUID | DRUG FOR FURTHER PROCESSING |
| Korsuva | difelikefalin | INJECTION, SOLUTION | NDA |
| RETACRIT | epoetin alfa-epbx | INJECTION, SOLUTION | BLA |
| RETACRIT | epoetin alfa-epbx | INJECTION, SOLUTION | BLA |
| RETACRIT | epoetin alfa-epbx | INJECTION, SOLUTION | BLA |
| RETACRIT | epoetin alfa-epbx | INJECTION, SOLUTION | BLA |
| RETACRIT | epoetin alfa-epbx | INJECTION, SOLUTION | BLA |
| RETACRIT | epoetin alfa-epbx | INJECTION, SOLUTION | BLA |
| VELTASSA | patiromer | POWDER, FOR SUSPENSION | NDA |
| VELTASSA | patiromer | POWDER, FOR SUSPENSION | NDA |
| VELTASSA | patiromer | POWDER, FOR SUSPENSION | NDA |
| VELTASSA | patiromer | POWDER, FOR SUSPENSION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.